Peter J. Dandliker

Papers

Total Citations

H-Index

About

Peter J. Dandliker is a leading figure in bioanalytical chemistry and drug discovery, with a focus on high-throughput mass spectrometry and metabolic stability assays. His pioneering work has revolutionized the efficiency of early-stage pharmaceutical development, particularly through the development of automated LC/MS/MS methods that enable rapid, sensitive, and selective screening of drug candidates. His most cited paper, "Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays" (2004, 38 citations), introduced a transformative approach that integrates automated sample preparation and fast-gradient liquid chromatography with tandem mass spectrometry, significantly accelerating the pace of metabolic profiling. This innovation directly addressed the bottleneck between high-throughput organic synthesis and biological evaluation, enabling researchers to assess drug metabolism with unprecedented speed and accuracy. Dandliker's contributions have been instrumental in streamlining the drug discovery pipeline, reducing time and resource costs while maintaining rigorous analytical standards. His work continues to influence modern bioanalytical strategies, making him a key figure in advancing the integration of automation and mass spectrometry in pharmaceutical research.